These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12603992)

  • 1. Using hospital antibiogram data to assess regional pneumococcal resistance to antibiotics.
    Stein CR; Weber DJ; Kelley M
    Emerg Infect Dis; 2003 Feb; 9(2):211-6. PubMed ID: 12603992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracking drug-resistant Streptococcus pneumoniae in Oregon: an alternative surveillance method.
    Chin AE; Hedberg K; Cieslak PR; Cassidy M; Stefonek KR; Fleming DW
    Emerg Infect Dis; 1999; 5(5):688-93. PubMed ID: 10511525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis.
    Sahm DF; Karlowsky JA; Kelly LJ; Critchley IA; Jones ME; Thornsberry C; Mauriz Y; Kahn J
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1037-42. PubMed ID: 11257013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents.
    Pihlajamäki M; Kotilainen P; Kaurila T; Klaukka T; Palva E; Huovinen P;
    Clin Infect Dis; 2001 Aug; 33(4):483-8. PubMed ID: 11462184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [1997-2007, 10 years of monitoring the evolution of resistance of Streptococcus pneumoniae to antibiotics in the region Centre; review of the Pneumococcus network].
    Holstein A; Amirault P; Arnould JP; Bachelier MN; Benseddik Z; Bret L; Cahiez M; Cattier B; Chandesris C; Chieux V; Courouble G; Domelier AS; Graveron JL; Harriau P; Lartigue MF; Laudat P; Poisson D; Secher A; Goudeau A; Lanotte P
    Pathol Biol (Paris); 2010 Feb; 58(1):62-6. PubMed ID: 19854585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrolide and fluoroquinolone (levofloxacin) resistances among Streptococcus pneumoniae strains: significant trends from the SENTRY Antimicrobial Surveillance Program (North America, 1997-1999).
    Jones RN; Pfaller MA
    J Clin Microbiol; 2000 Nov; 38(11):4298-9. PubMed ID: 11185065
    [No Abstract]   [Full Text] [Related]  

  • 7. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin.
    Felmingham D; Reinert RR; Hirakata Y; Rodloff A
    J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():25-37. PubMed ID: 12239226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Istanbul.
    Gönüllü N; Berkiten R
    Int J Antimicrob Agents; 2000 Sep; 16(1):77-8. PubMed ID: 10958574
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical impact of macrolide resistance in pneumococcal respiratory infections.
    Garau J
    Int J Antimicrob Agents; 2001; 18 Suppl 1():S33-8. PubMed ID: 11574193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in antimicrobial resistance of Streptococcus pneumoniae in Japan.
    Yoshida R; Kaku M; Kohno S; Ishida K; Mizukane R; Takemura H; Tanaka H; Usui T; Tomono K; Koga H
    Antimicrob Agents Chemother; 1995 May; 39(5):1196-8. PubMed ID: 7625816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National antimicrobial resistance surveillance among clinical isolates of Streptococcus pneumoniae in Thailand.
    Dejsirilert S; Tienkrim S; Ubonyaem N; Sawanpanyalert P; Aswapokee N; Suankratay C
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S19-33. PubMed ID: 21298844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotype distribution and antimicrobial resistance of adult Streptococcus pneumoniae clinical isolates over the period 2001-2008 in Crete, Greece.
    Maraki S; Mantadakis E; Samonis G
    Chemotherapy; 2010; 56(4):325-32. PubMed ID: 20720416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of oral agents against pediatric isolates of Streptococcus pneumoniae.
    Black J; Moland ES; Chartrand SA; Thomson KS
    Diagn Microbiol Infect Dis; 2001 Mar; 39(3):195-7. PubMed ID: 11337189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998.
    Thornsberry C; Jones ME; Hickey ML; Mauriz Y; Kahn J; Sahm DF
    J Antimicrob Chemother; 1999 Dec; 44(6):749-59. PubMed ID: 10590275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of resistance to macrolides in invasive Streptococcus pneumoniae in Spain (2000-2001).
    Oteo J; Campos J; Cruchaga S; Baquero G; Lázaro E; Madurga M; de Abajo FJ; Baquero F;
    Clin Microbiol Infect; 2004 Sep; 10(9):851-4. PubMed ID: 15355420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of drug-resistant pneumococcal infections in the United States.
    Breiman RF; Butler JC; Tenover FC; Elliott JA; Facklam RR
    JAMA; 1994 Jun; 271(23):1831-5. PubMed ID: 8196139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.
    Mason EO; Wald ER; Bradley JS; Barson WJ; Kaplan SL;
    Pediatr Infect Dis J; 2003 Jul; 22(7):623-7. PubMed ID: 12867838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and antimicrobial resistance of Streptococcus pneumoniae in France in 2007: data from the pneumococcus surveillance network.
    Kempf M; Baraduc R; Bonnabau H; Brun M; Chabanon G; Chardon H; Croizé J; Demachy MC; Donnio PY; Dupont P; Fosse T; Gibel L; Gravet A; Grignon B; Hadou T; Hamdad F; Joly-Guillou ML; Koeck JL; Maugein J; Péchinot A; Ploy MC; Raymond J; Ros A; Roussel-Delvallez M; Segonds C; Vergnaud M; Vernet-Garnier V; Lepoutre A; Gutmann L; Varon E; Lanotte P
    Microb Drug Resist; 2011 Mar; 17(1):31-6. PubMed ID: 20809835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4.
    Jenkins SG; Brown SD; Farrell DJ
    Ann Clin Microbiol Antimicrob; 2008 Jan; 7():1. PubMed ID: 18190701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of pbp2b and ermB genes in clinical isolates of Streptococcus pneumoniae.
    Kumari N; Navaratnam P; Sekaran SD
    J Infect Dev Ctries; 2008 Jun; 2(3):193-9. PubMed ID: 19738350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.